5 Top-Ranked Tech Stocks to Buy Ahead of Thanksgiving

The three major U.S. indices, namely, the Dow Jones Industrial Average, the S&P 500 and the Nasdaq began the thanksgiving week on a bright note, courtesy encouraging vaccine data from AstraZeneca AZN and the University of Oxford.

The AstraZeneca-University of Oxford vaccine has shown 90% effectiveness. Notably, in late stage trials, vaccines developed by Pfizer and its German partner BioNTech have been found 95% effective, while Moderna’s shot is 94.5% effective. Meanwhile, Regeneron’s COVID-19 antibody treatment received emergency use authorization from the FDA.

The positive development on the vaccine front is great news for the United States, which has been seeing rising number of COVID-19 cases over the past few weeks. According to John Hopkins University data, more than 12 million people have been infected in the United States, with the death toll hitting 257,701 as of Nov 23.

Per a Reuters report, Dr. Moncef Slaoui, chief scientific adviser for

Read More

BlackRock ups U.S. stocks to overweight, bullish on tech

FILE PHOTO: A sign for BlackRock Inc hangs above their building in New York U.S., July 16, 2018

LONDON (Reuters) – BlackRock, the world’s largest asset manager, has upgraded U.S. equities to “overweight”, turning bullish on quality large cap technology companies as well as small cap firms that tend to perform well during a cyclical upswing.

The asset manager said it prefers the United States as it “boasts” a higher share of “quality” companies with strong balance sheets and free cash flow generation in the high-flying tech and healthcare sectors.

The resurgence in virus cases in Europe and the United States could led to further outperformance of large cap tech and healthcare companies, it added.

In turn, BlackRock turned bearish on Europe.

In a note on Monday, BlackRock said it downgraded European equities to “underweight”, just three weeks after cutting allocations to “neutral”. It cited the region’s high exposure to

Read More

Are These The Best Tech Stocks To Watch Before December 2020?

3 Top Tech Stocks to Watch This Week

Tech stocks have had a fantastic year in the stock market thus far. Certain tech companies have especially benefited from anti coronavirus measures. Social distancing and lockdowns have undoubtedly shifted the focus of consumers, companies, and the general public towards online services. Top tech stocks such as Roku (ROKU Stock Report) and Netflix (NFLX Stock Report) have seen phenomenal year-to-date growth. Why is this so, you might ask?

Simply put, these tech companies have been and will continue to meet the needs of people who are staying home. Despite news of potential coronavirus vaccine candidates from Pfizer (PFE Stock Report) and Moderna (MRNA Stock Report), these tech companies will still continue to prosper. Investors are generally aware that it could be months before the vaccine can be distributed to the public. In the meantime, people will continue to heavily rely on such

Read More

Stocks rise on cyclical boost but megacaps curb gains

NEW YORK (Reuters) – U.S. stocks rose in a choppy session on Monday as hopes for a COVID-19 vaccine boosted economically sensitive sectors such as energy and industrials, but a pullback in megacap shares held gains in check.

FILE PHOTO: The New York Stock Exchange (NYSE) is seen as people walk in silhouette in the financial district of New York, U.S., November 19, 2020. REUTERS/Shannon Stapleton

Cyclical sectors led gains, with energy ahead by more than 5% and industrials and financials each up more than 1%, as data showed monthly business activity expanded at the fastest rate in more than five years.

Energy shares also got a boost from oil prices, which have risen on anticipation a vaccine will help demand recover.

But declines in technology and tech-related heavyweight names such as Apple Inc and Facebook Inc muted gains as investors rotated out of stocks seen as safe bets following

Read More

Stocks edge higher on Wall Street on latest vaccine hopes

Stocks edged higher in afternoon trading Monday after investors received several pieces of encouraging news on COVID-19 vaccines and treatments, tempering concerns over rising virus cases and business restrictions

The benchmark S&P 500 index rose 0.3%, led by banks, industrial companies and other businesses that have been beaten down by the virus.

The latest vaccine developments are helping to raise hopes that some normalcy will eventually be restored to everyday life and the economy. It is also tempering lingering concerns about new government controls as the virus spikes in

Read More

U.S. Stocks Rise on Reopening Rotation; Gold Drops: Markets Wrap

(Bloomberg) — U.S. stocks churned higher as investors piled into companies that will benefit most from a return to normal economic activity. Tech shares lagged behind, while gold slumped.

Loading...

Load Error

The S&P 500 Index rose in afternoon trading that was 5% below the 30-day average. The Nasdaq 100 extended losses into a second day. AstraZeneca Plc became the latest firm to deliver positive vaccine developments, bolstering demand for cruise-line operators and airlines. Stocks had been weaker on news that cases continued to surge around the country and after New York’s mayor warned the city would be in “dire, dire shape” without additional federal aid.

Vaccine successes lately have added to a risk-on mood in markets and investors have snapped up assets that could benefit from the end of lockdowns and travel restrictions even as the virus rages across the nation. Investors have also started to anticipate Congress will again

Read More

Top analysts say buy stocks like Amazon & Yelp

Jin Lee | Bloomberg | Getty Images

Out on Wall Street, stocks are taking a breather from this month’s rally. Despite encouraging updates on a potential coronavirus vaccine, disappointing unemployment data and a spike in coronavirus cases have spooked investors.

Not helping investor sentiment, New York City Mayor Bill de Blasio announced that schools would return to remote learning to mitigate the virus’ spread.

“The market has really been in a celebratory mode since Election Day and rode through it again last week. I think the idea now is people are beginning to consider taking some profits ahead of expectations that taxes related to capital gains could rise in 2021. I also think there’s the consideration of the transition in COVID to post-COVID… Even with the resurgence, all the vaccine news tells us [is] there is a post-COVID ahead,” Oppenheimer’s Chief Investment Strategist John Stoltzfus noted.

As plenty of question

Read More

Forget Bitcoin! Buy These 3 Tech Stocks Instead

Bitcoin has surged in 2020, with its price climbing roughly 150% year to date. After many months of volatile trading, the cryptocurrency has climbed back to the range of $18,000 per coin — not far from the high of $19,738 per coin it hit at the end of 2017. With its price surging, bitcoin is generating tons of excitement again, but there could be even better investment opportunities in the technology sector.

We asked three Motley Fool contributors to profile a tech stock that they think will outperform bitcoin. Read on to see why they identified Impinj (NASDAQ: PI), Square (NYSE: SQ), Advanced Micro Devices (NASDAQ: AMD) as investments that could deliver big returns.

A coin with a bitcoin sign on it.

Image source: Getty Images.

Seeking huge returns? Trends are your friend

Keith Noonan (Impinj): I haven’t invested in bitcoin because I don’t understand it. I’ve researched it along with other cryptocurrencies, but I

Read More

These 3 Dividend Stocks Are Practically Money Machines

Many investors buy dividend stocks for one reason: They want a reliable income stream.

Some stocks generate larger income streams, while others provide more reliability. If you’re looking for both, check out these three dividend stocks. 

1. AbbVie

You just might drool over AbbVie‘s (NYSE:ABBV) dividend yield of close to 5.2%. You’ll also almost certainly love the drugmaker’s dividend track record. AbbVie is a Dividend Aristocrat — a term for S&P 500 members that have increased their dividends for at least 25 consecutive years.

$100 bills in a money printing machine.

Image source: Getty Images.

Could the looming entrance of biosimilar rivals to AbbVie’s top-selling drug Humira in the U.S. market threaten the company’s dividend? I don’t think so. First, Humira’s sales won’t totally evaporate overnight when biosimilars hit the U.S. market in 2023. More importantly, AbbVie has plenty of other products to generate revenue.

Rinvoq and Skyrizi appear to be worthy successors to Humira. AbbVie’s

Read More

3 Incredibly Cheap 5G Tech Stocks

Many tech investors are bullish on the growth potential of fifth-generation (5G) networks, which could transfer data up to 100 times faster than 4G networks. Those faster speeds could spur fresh sales of network hardware, faster phones, and innovative new devices and services across the Internet of Things.

Earlier this month, I highlighted a few 5G stocks that will reward patient investors with decent dividends. Today, I want to take a closer look at three 5G stocks that are also cheap relative to their growth potential: China Mobile (NYSE:CHL), Ericsson (NASDAQ:ERIC), and Broadcom (NASDAQ:AVGO). Let’s take a closer look at these tech stocks.

An illustration of a 5G chip.

Image source: Getty Images.

1. China Mobile

China Mobile, the Middle Kingdom’s top telecom company, provided services for 946.2 million wireless subscribers in September, up 0.4% from a year ago. Its number of 4G customers rose 3% to 769.5 million, as its 5G customer

Read More